36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities
36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities
复制标题
第 36 届贝塞斯达会议：患有心血管异常的竞技运动员的资格建议
DOI：
--
复制
发表时间：
2005
期刊：
影响因子：
--
通讯作者：
S. Gidding
中科院分区：
文献类型：
--
作者：
M. Ackerman;G. Balady;R. Bonow;B. Chaitman;M. Cheitlin;L. Clark;M. Crawford;W. Gersony;S. Gidding
本报告中提出的建议是会议与会者的建议，并不一定反映美国心脏病学会基金会的官方立场。这份第36届贝塞斯达会议报告是2004年11月6日在路易斯安那州新奥尔良举行的协商一致会议的结果。共识会议旨在促进对有关心血管医学实践的重大和及时的问题的审议，以及影响患者护理、研究和培训的事项，这些问题的绝对数据或硬数据不完整。邀请美国心脏病学会基金会(ACCF)以外的其他适当组织根据每个主题的适当情况派遣代表参与这一进程。这些人可能包括医生和卫生保健专家，以及来自行业、政府、基金会和公共部门的代表。发布一份报告，强调建议，如果合适的话，还会附上不同意见。本报告中提出的建议仅供与会者参考，并不一定反映协调委员会的官方立场。临床专家共识工作组认识到保持高道德标准和避免利益冲突的重要性。由于这份会议报告的发展依赖于其志愿者的知识和经验，他们中的许多人与行业有关系，因此撰写委员会成员关系的政策必须是现实的、可行的，并以一种保护过程完整性的方式实施，同时允许公开和诚实的信息交流。因此，工作队为收集可能被视为与会议活动有关的实际或潜在利益冲突的所有与会者关系的披露声明提供了便利，并将这一信息与会议报告一起公布。有关披露作者的信息，请参阅每个工作队报告的附录。本届第36届贝塞斯达会议的焦点是被确认为心血管异常的训练有素的运动员。目标是正式制定关于这些个人是否有资格参加有组织体育比赛的谨慎共识建议，并以临床医生易于使用的形式提出这些考虑因素。本文件是第16次(1985年)(第1次)和最近第26次(1994年)(第2次)贝塞斯达会议的更新。我们再次尝试通过一个专家小组的共识来确定哪些心血管异常(以及严重程度)会增加竞技运动员突发…的风险
The recommendations set forth in this report are those of the Conference participants and do not necessarily reflect the official position of the American College of Cardiology Foundation. This 36th Bethesda Conference report is the result of a consensus conference held on November 6, 2004, in New Orleans, Louisiana. Consensus conferences are designed to facilitate consideration of significant and timely issues regarding the practice of cardiovascular medicine and matters affecting patient care, research, and training for which absolute or hard data are incomplete. Appropriate organizations other than the American College of Cardiology Foundation (ACCF) are invited to send representatives to participate in the process, as appropriate to each topic. These may include physicians and health care specialists as well as representatives from industry, government, foundations , and the public sector. A report is published to highlight recommendations, along with dissenting opinion, if appropriate. The recommendations set forth in this report are those of the conference participants only and do not necessarily reflect the official position of the ACCF. The Task Force on Clinical Expert Consensus recognizes the importance of maintaining high ethical standards and avoiding conflicts of interests. Because the development of this conference report depends on the knowledge and experience of its volunteers, many of whom have relationships with industry, the policy for writing committee members' relationships must be realistic , workable, and implemented in a way that protects the integrity of the process while allowing an open and honest exchange of information. Therefore, the Task Force facilitates a process for collection of disclosure statements of all relationships of conference participants that might be perceived as real or potential conflicts of interest relevant to the conference activity and publishes this information with the conference report. Please refer to the appendix of each Task Force report for author disclosure information. The focus of this 36th Bethesda Conference is the trained athlete with an identified cardiovascular abnormality. The goal is to formally develop prudent consensus recommendations regarding the eligibility of such individuals for competition in organized sports, and to present these considerations in a readily useble format for clinicians. This document constitutes an update of the 16th (in 1985) (1) and more recent 26th (in 1994) (2) Bethesda Conferences. Once again, we have attempted to ascertain by the consensus of an expert panel which cardiovascular abnormalities (and with what degree of severity) place the competitive athlete at increased risk for sudden …
登录
查看更多内容
影响因子：
158.5
作者：
Gott, VL;Greene, PS;Pyeritz, RE
通讯作者：
Pyeritz, RE
影响因子：
158.5
作者：
SHORES, J;BERGER, KR;PYERITZ, RE
通讯作者：
PYERITZ, RE
影响因子：
120.7
作者：
Greenland, P;LaBree, L;Detrano, RC
通讯作者：
Detrano, RC
DOI：
10.1172/jci18062
发表时间：
2003-10
期刊：
The Journal of clinical investigation
影响因子：
--
作者：
D. Benson;Dao-wu Wang;M. Dyment;T. Knilans;F. Fish;M. Strieper;T. H. Rhodes;A. George
通讯作者：
D. Benson;Dao-wu Wang;M. Dyment;T. Knilans;F. Fish;M. Strieper;T. H. Rhodes;A. George
影响因子：
158.5
作者：
Albert, CM;Mittleman, MA;Manson, JE
通讯作者：
Manson, JE